Jackson Acquisition Company II (JACS.U) Prices $200M IPO
by Nicholas Alan Clayton on 2024-12-10 at 7:49am

Jackson Acquisition Company II (NYSE:JACS.U) announced the pricing of its $200 million IPO and its units are expected to begin trading on the NYSE under the symbol “JACS.U”, Tuesday, December 10 2024.

The new SPAC intends to search for a healthcare target that can benefit from its team’s relationships within the healthcare services space nationally.

Jackson II’s sponsor team is led by Chief Executive Officer and Director Richard L. Jackson and Chief Financial Officer David Lawrence. Brian A. McCarthy, J. Nicholas Ayers, Stephan S. Rodgers, and Paul G. Gabos will serve on its Board of Directors.

Total SPAC deal count for 2024 year-to-date is now 53. This offering is expected to close on Wednesday, December 11, 2024.


Roth Capital Partners is acting as the sole book running manager for the initial public offering. Nelson Mullins Riley & Scarborough LLP is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2025-01-13 at 4:07pm

Live Oak Acquisition Corp. V (NASDAQ:LOKVU) has filed for a $200 million IPO that brings another serial SPAC team back to the mix for a generalist search but with a pair of technology deals already in their pocket. The new S-1 also puts Santander on the board for the 2025 SPAC market after it made...

by Nicholas Alan Clayton on 2025-01-13 at 1:40pm

CH4 Natural Solutions (NYSE:MTNE.U) has filed for a $250 million SPAC to bring both the Riverstone sponsor team and underwriter Citigroup back to the market for 2025. The team secured notably sponsor-friendly terms for the vehicle and will not overfund its trust. In fact, along with fellow Friday filer Live Oak V (NASDAQ:LOKVU), these two...

by Nicholas Alan Clayton on 2025-01-13 at 8:16am

At the SPAC of Dawn  Amid a restive market, SPACs have front-loaded their business this week with three of their four votes set for today and tomorrow. One of these is a completion vote, in which Bowen (NASDAQ:BOWN) will try and secure shareholder approval for its combination with Shenzhen Qianzhi BioTechnology just after having gained...

by Kristi Marvin on 2025-01-11 at 10:21am

Terms Tracker for the Week Ending January 10, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This was the first full week in January and the first non-holiday week since December 23rd. All the same, 2025 has started with a bang...

by Nicholas Alan Clayton on 2025-01-10 at 3:45pm

Origin Investment Corp I has filed for a $60 million SPAC to hunt for an Asian target outside of China and marks ThinkEquity’s entry into the 2025 SPAC IPO market. ThinkEquity took all of 2024 off from directly underwriting SPACs as a left lead and has not brought one all the way to IPO since...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved